| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
5e-11 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-10 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
3e-09 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-08 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-07 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-07 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |